BioNTech SE (BNTX)
108.23
+6.09
(+5.96%)
USD |
NASDAQ |
Nov 21, 16:00
108.77
+0.54
(+0.50%)
After-Hours: 20:00
BioNTech 1 Year Total Returns (Daily): 11.39% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 11.39% |
November 20, 2024 | 3.35% |
November 19, 2024 | 7.05% |
November 18, 2024 | 2.50% |
November 15, 2024 | -0.98% |
November 14, 2024 | 2.88% |
November 13, 2024 | 13.84% |
November 12, 2024 | 6.79% |
November 11, 2024 | 9.21% |
November 08, 2024 | 11.06% |
November 07, 2024 | 5.38% |
November 06, 2024 | 6.95% |
November 05, 2024 | 15.86% |
November 04, 2024 | 13.77% |
November 01, 2024 | 19.29% |
October 31, 2024 | 20.91% |
October 30, 2024 | 22.19% |
October 29, 2024 | 25.01% |
October 28, 2024 | 24.19% |
October 25, 2024 | 15.99% |
October 24, 2024 | 16.63% |
October 23, 2024 | 19.95% |
October 22, 2024 | 21.97% |
October 21, 2024 | 22.74% |
October 18, 2024 | 18.43% |
Date | Value |
---|---|
October 17, 2024 | 18.51% |
October 16, 2024 | 21.42% |
October 15, 2024 | 13.47% |
October 14, 2024 | 15.99% |
October 11, 2024 | 8.64% |
October 10, 2024 | 6.48% |
October 09, 2024 | 7.46% |
October 08, 2024 | 8.17% |
October 07, 2024 | 9.30% |
October 04, 2024 | 11.28% |
October 03, 2024 | 9.58% |
October 02, 2024 | 5.54% |
October 01, 2024 | 10.39% |
September 30, 2024 | 9.32% |
September 27, 2024 | 14.64% |
September 26, 2024 | 15.49% |
September 25, 2024 | 12.30% |
September 24, 2024 | 13.22% |
September 23, 2024 | 8.04% |
September 20, 2024 | 3.38% |
September 19, 2024 | 1.88% |
September 18, 2024 | 6.03% |
September 17, 2024 | 10.30% |
September 16, 2024 | 9.21% |
September 13, 2024 | 8.96% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.37%
Minimum
Aug 09 2022
627.1%
Maximum
Oct 16 2020
69.66%
Average
-16.35%
Median
1 Year Total Returns (Daily) Benchmarks
Novavax Inc | 50.28% |
DBV Technologies SA | -69.87% |
Akari Therapeutics PLC | -59.35% |
Biodexa Pharmaceuticals PLC | -93.69% |
NuCana PLC | -87.61% |